Allergy, Immunology and Rheumatology

Our clients benefit from our thorough approach with feasibility for timely project delivery milestones in these therapeutic areas.

As a leading full service CRO, PSI provides the services required to support global clinical trials, offering in-depth therapeutic experience across Phase I-IV clinical programs. We provide you with the expertise that is needed to conduct your clinical trial, whether it is a Phase I study, proof-of-concept or rescuing a pivotal study where enrollment is behind schedule; our goal is to complete your study on time!

For allergy, immunology and rheumatology studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience and relationships with investigators to manage and support their efforts to meet enrollment goals.

PSI has successfully performed Phase II/III studies in the following allergy, immunology & rheumatology indications:

PSI employs physicians as full-time monitors and project managers, the majority of whom are board certified specialists, including pulmonologists, immunologists and rheumatologists.

Please contact PSI to learn more about our allergy, immunology and rheumatology therapeutic expertise that can help you achieve on-time enrollment, meeting your study goals.

Case Study Examples: Rheumatoid Arthritis Clinical Trial, Ulcerative Colitis Clinical Trial, Gout Clinical Trial, Vienna Challenge Chamber Clinical Trial, VCC Collaboration